Pain Pod

Sports Pharmacy: Play Ball! | Pain Pod

This episode of the Pain Pod takes a moment to sit down with THE Pharmacist Athlete, Dr. Brandon Welch!What is sports pharmacy? Patient athletes? Where does a pharmacist fit into sports teams? All of this and much, much more. Perhaps even a little inspiration to figure out your dreams and live them out!Come one, come all, to the Pain Pod!!!Pain Guy• www.painguy.usPharmacy Athlete• https://pharmacyathlete.com/ 

Journavx: A Quick Journey into the Novel Non-Opioid Pain Med | Pain Pod

Extra Extra, Read all about it! Actually, it’s a podcast, Listen all about it! New Pain Med! New Pain Med! New Non-Opioid Pain Med!Suzetrigine (Journavx) is now FDA Approved for Moderate to Severe Acute Pain in Adults, but what fun facts come along with it?????We turn to the Simpsons, Brugada, and enjoy some club seats while succinctly reviewing everything there is to know about this new non-opioid pain medication on the Pain Pod!Come one, come all, to the Pain Pod!!!Pain Guy• www.painguy.us
 

Pain Pearls: Part 1 | Pain Pod

Clinical Pearls, Pain Pod edition: Pain Pearls Part 1 (of many)!A cornucopia of pain conundrums and potential solutions and/or tools to help mitigate. All here, nicely packaged, randomly, in one episode of the Pain Pod! One of many more to come, in a miniseries titled: “Pain Pearls”, only here on the Pain Pod!Come one, come all, to the Pain Pod!!!P.S. Want to contribute or hear about a pain pearl of your own? Message Pain Guy on www.painguy.us to directly reach Mark and have your voice heard!Pain Guy• www.painguy.usDVPRS (Pain Scale)• https://www.va.gov/PAINMANAGEMENT/docs/DVPRS_2slides_and_references.pdf Opioid Risk Screenings• www.opioidrisk.com 2022 CDC Opioid Guideline Update• Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022. MMWR Recomm Rep 2022;71(No. RR-3):1–95.Buprenorphine Induction Resources• Kampman K and Jarvis M. American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use. J Addict Med. Sep-Oct 2015;9(5):358-67.• Ahmed, S. Bhivandkar S, et. al. Microinduction of Buprenorphine/Naloxone: A Review of the Literature. The American Journal on Addictions, 30: 305–315, 2021.• Privia A. Randhawa, Rupinder Brar and Seonaid Nolan. Buprenorphine–naloxone “microdosing”: an alternative induction approach for the treatment of opioid use disorder in the wake of North America’s increasingly potent illicit drug market CMAJ January 20, 2020 192 (3) E73.MOUD Minimum Durations Study• Michael L. Dennis, Mark A. Foss, and Christy K. Scott. An Eight-Year Perspective on the Relationship Between the Duration of Abstinence and Other Aspects of Recovery. Evaluation Review 2007 31:6, 585-612

Thug Drugs: GABA, GABA, GABA | Pain Pod

GABBA, GABBA, GABBA!!! It’s time to enter the matrix with Pain Guy, the matric of the neural synaptic cleft, that’s where it’s at for this episode of the Pain Pod folks! We’ll chat through all types of gabapentinoids including roofies, benzos, and of course gabapentin amongst others. So get out of your seat and jump around before the Gabba receptor sits you down!You’re not going to want to miss this one!Come one, come all, to the Pain Pod!!!Pain Guy• www.painguy.us

Guess Who’s Back! Back Again! Topical Pain Medications Part 2: An Rx Encore! | PainPod

Topical medications are utilized around the globe at appreciatively higher rates than in our country, so what’s the barriers? “Knowledge” is a great place to start, so join us on this episode of the Pain Pod to go deeper (pun completely intended) into topical pain medications, and in this sequel episode we’ll build upon the OTC topical pain medications discussed in the last episode by diving into the Rx’s!Come one, come all, to the Pain Pod!!!Pain Guy• www.painguy.us

Oh Yeah! Topical Pain Medications! | Pain Pod

Topical medications are utilized around the globe at appreciatively higher rates than in our country, so what’s the barriers? “Knowledge” is a great place to start, so join us on this episode of the Pain Pod to go deeper (pun completely intended) into topical pain medications!Come one, come all, to the Pain Pod!!!Pain Guy• www.painguy.us

Flags, Fires, & Airports: A Chat with Ron Chapman, Legal Expert | Pain Pod

Is every red flag Red a fire or smoke? Controlled substance red flags alert a clinician to needed further conversation, but is every red flag (smoke) investigated for the fire? This episode of the Pain Pod continues the conversation on controlled substance red flags, corresponding legal responsibility, and the opioid crisis, yet with the expertise of a very well-known legal expert, Ron Chapman.You’re not going to want to miss this chat!Come one, come all, to the Pain Pod!!!Pain Guy• www.painguy.usPain Guy’s Practical Pain Management “Controlled Substance Concerns” Article• Garofoli MP, “Prescribing and Dispensing Controlled Substances: When to Pump the Brakes”. Practical Pain Management. 2022; 22(6).• https://www.practicalpainmanagement.com/issue202206/prescribing-and-dispensing-controlled-substances-when-to-pump-the-brakes Drug Topics Chain Pharmacies Red Flags Article• https://www.drugtopics.com/view/national-pharmacy-chain-opioid-settlements-poised-to-affect-independent-pharmacies Chapman Law Group https://www.chapmanlawgroup.com/

Trauma, Pain, & Addiction | Pain Pod

Remember Pain Guy’s TEDx talk “Mise en Scene: Pain, Addiction, and YOU”? It was all about the cinematic experience, right? Well on this episode of the Pain Pod, we welcome Helen Sairany, an author and pharmacist known all across our globe (yes, internationally!) for her countless efforts to educate and help folks improve and save lives in respect to trauma. Helen digs into the roots of pain, addiction, trauma, and childhood experiences like no other!Pain Guy knows many people that just couldn’t put her books down. So now it’s time to hear directly from her on the Pain Pod!Come one, come all, to the Pain Pod!!!

National Opioid Settlement: Beyond the $45 BILLION | Pain Pod

FORTY-FIVE BILLION DOLLARS (approximately of course) and an appreciable number of concrete efforts and responsibilities, that’s the National Opioid Settlement!On this episode of the Pain Pod, we discuss the details of the National Opioid Settlement in respect to financials, controlled substance programs, and specifically the “red flags” stated within. We’re American (although, there are Pain Pod international listeners!), and this affects literally everyone in our communities, families, friends, and professions, so let’s take a moment to review the in’s and out’s of the $45B and much, much more.Come one, come all, to the Pain Pod!!!National Opioid Settlement• www.nationalopioidsettlement.comPain Guy• www.painguy.us• National Opioid Settlement Link on Pain Guy Website: https://painguy.us/resources Pain Guy’s Practical Pain Management “Controlled Substance Concerns” Article• Garofoli MP, “Prescribing and Dispensing Controlled Substances: When to Pump the Brakes”. Practical Pain Management. 2022; 22(6).• https://www.practicalpainmanagement.com/issue202206/prescribing-and-dispensing-controlled-substances-when-to-pump-the-brakes 

Cannabis & Chronic Pain: A Chat with Dr. Ken Finn | Pain Pod

On the last episode of the Pain Pod, we succinctly reviewed all things Cannabis and Cannabinoids including the history, botany, regulations, pharmacology, and clinical utilizations of Cannabis, THC, and CBD. Now it’s time to go one giant leap forward in the realm of pain management, with THE international expert Dr. Kenneth Finn!You’re not going to want to miss this one!Come one, come all, to the Pain Pod!!!Pain Guy• www.painguy.usCannabis in Medicine: An Evidence-Based Approach (2020)• https://link.springer.com/book/10.1007/978-3-030-45968-02021 International Association for the Study of Pain Task Force• https://journals.lww.com/pain/fulltext/2021/07001/international_association_for_the_study_of_pain.1.aspxCBD for Pain: Ineffective, Expensive, and with Potential Harms (Journal of Pain, October 2023)• https://www.jpain.org/article/S1526-5900(23)00582-5/fulltext